EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Efficacy of oral vs. intratympanic corticosteroids in sudden sensorineural hearing loss

Kavita Swachia, Dinesh Sharma, Jatinder Singh

Journal of Basic and Clinical Physiology and Pharmacology · 01.06.2016 · 27 (4) · 371-377

DOI: 10.1515/jbcpp-2015-0112 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Basic and Clinical Physiology and Pharmacology, online erschienen am 14.01.2016. Verfasst von Kavita Swachia und 2 weiteren Autor:innen. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The current standard treatment for sudden sensorineural hearing loss (SSNHL) comprises of tapered course of oral corticosteroids. Intratympanic steroids are introduced as another modality of treatment, but management of SSNHL continues to be debatable. The present study was designed to evaluate the efficacy of steroids given orally and by the intratympanic route.

Methods

A prospective, randomized, open-labeled study was conducted involving 42 patients. These were randomly divided into two groups; group I patients received oral prednisone tapered over 14 days, and group II patients were treated with intratympanic methylprednisolone (40 mg/mL). One milliliter of the drug solution containing 40 mg of the drug (40 mg/mL) was injected into the middle ear cavity through the trans-tympanic route. The drug was injected twice a week for 2 weeks. The total duration of the study was 60 days, and hearing outcome was assessed on the basis of change in pure tone average.

Results

An improvement of 18.24±8.72 dB was recorded in group I patients treated with oral prednisone in comparison to 14.68±12.88 dB improvement in group II. Statistically significant improvement in hearing was observed in both groups, but it was not significant when group I and group II were compared.

Conclusions

The post-treatment outcomes among patients who receive either oral prednisone or intratympanic methylprednisolone within 2 weeks of onset of symptoms were comparable. The outcomes were affected by degree of hearing loss and association of SSNHL with vertigo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Administration, OralAdolescentAdrenal Cortex HormonesAdultAgedEar, MiddleFemaleHearingHearing Loss, SensorineuralHumansInjection, IntratympanicMaleMethylprednisoloneMiddle AgedProspective StudiesTreatment OutcomeTympanic MembraneYoung Adult

Substanzen

Adrenal Cortex HormonesMethylprednisolone

Zitieren

APA

Swachia, K., Sharma, D., & Singh, J. (2016). Efficacy of oral vs. intratympanic corticosteroids in sudden sensorineural hearing loss. Journal of Basic and Clinical Physiology and Pharmacology, 27(4), 371-377. https://doi.org/10.1515/jbcpp-2015-0112

Vancouver

Swachia K, Sharma D, Singh J. Efficacy of oral vs. intratympanic corticosteroids in sudden sensorineural hearing loss. Journal of Basic and Clinical Physiology and Pharmacology. 2016;27(4):371-377. doi:10.1515/jbcpp-2015-0112

BibTeX
@article{Swachia2016,
  author = {Swachia, Kavita and Sharma, Dinesh and Singh, Jatinder},
  title = {Efficacy of oral vs. intratympanic corticosteroids in sudden sensorineural hearing loss},
  journal = {Journal of Basic and Clinical Physiology and Pharmacology},
  year = {2016},
  volume = {27},
  number = {4},
  pages = {371--377},
  doi = {10.1515/jbcpp-2015-0112}
}
Kostenlos starten →